Catalog Products » Putative lipid scramblase CLPTM1 Antibody, mAb, Rabbit
Manual
Manual
COAs

Putative lipid scramblase CLPTM1 Antibody, mAb, Rabbit

Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER). Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.
$210.00
A05404-50

Ask us a question
Overview
Specificity This product is specific to Putative lipid scramblase CLPTM1
Host Species Rabbit
Immunogen A synthesized peptide derived from human Putative lipid scramblase CLPTM1
Species Reactivity Human
Conjugate Unconjugated
Back

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Western Blot 1:1000-1:2000
Immunohistochemistry (IHC) 1:100-1:200
Immunocytochemistry/Immunofluorescence (ICC/IF) 1:50-1:200
Immunohistochemistry Frozen (IHF) 1:50-1:200
Flow Cytometry 1:20-1:100
Back

Properties
Form Liquid
Storage Buffer Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed.
Purification Affinity-chromatography
Isotype Rabbit IgG
Clonality Monoclonal
Back

Putative Lipid Scramblase CLPTM1 Antibody, MAb, Rabbit

Western blot analysis of CLPTM1 expression in HepG2 cell lysate. »

<
>

Background
Target Background Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER). Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.
Synonyms HS9; N14;
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.